Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Quest Diagnostics stock

DGX
US74834L1008
904533

Price

160.26
Today +/-
+8.27
Today %
+5.43 %

Quest Diagnostics stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Quest Diagnostics stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Quest Diagnostics stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Quest Diagnostics stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Quest Diagnostics's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Quest Diagnostics Stock Price History

DateQuest Diagnostics Price
1/10/2025160.26 undefined
1/10/2025151.79 undefined
1/8/2025154.03 undefined
1/7/2025153.64 undefined
1/6/2025152.27 undefined
1/3/2025151.92 undefined
1/2/2025150.96 undefined
12/31/2024150.86 undefined
12/30/2024150.97 undefined
12/27/2024152.63 undefined
12/26/2024153.02 undefined
12/24/2024153.42 undefined
12/23/2024152.94 undefined
12/20/2024153.10 undefined
12/19/2024151.52 undefined
12/18/2024151.25 undefined
12/17/2024155.49 undefined
12/16/2024152.65 undefined
12/13/2024155.00 undefined

Quest Diagnostics Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Quest Diagnostics, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Quest Diagnostics from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Quest Diagnostics’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Quest Diagnostics. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Quest Diagnostics’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Quest Diagnostics’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Quest Diagnostics’s growth potential.

Quest Diagnostics Revenue, EBIT and net profit per share

DateQuest Diagnostics RevenueQuest Diagnostics EBITQuest Diagnostics Net Income
2028e11.4 B undefined1.88 B undefined1.43 B undefined
2027e11.11 B undefined1.78 B undefined1.3 B undefined
2026e11.19 B undefined1.82 B undefined1.2 B undefined
2025e10.79 B undefined1.71 B undefined1.1 B undefined
2024e9.93 B undefined1.52 B undefined1 B undefined
20239.25 B undefined1.32 B undefined850 M undefined
20229.88 B undefined1.52 B undefined942 M undefined
202110.79 B undefined2.5 B undefined1.99 B undefined
20209.44 B undefined1.99 B undefined1.43 B undefined
20197.73 B undefined1.32 B undefined855 M undefined
20187.53 B undefined1.23 B undefined733 M undefined
20177.4 B undefined1.27 B undefined769 M undefined
20167.52 B undefined1.24 B undefined642 M undefined
20157.49 B undefined1.1 B undefined706 M undefined
20147.44 B undefined1.03 B undefined554 M undefined
20137.15 B undefined1.12 B undefined846 M undefined
20127.38 B undefined1.32 B undefined553.2 M undefined
20117.39 B undefined1.3 B undefined467.7 M undefined
20107.26 B undefined1.32 B undefined717.6 M undefined
20097.46 B undefined1.35 B undefined726.9 M undefined
20087.25 B undefined1.22 B undefined580.2 M undefined
20076.7 B undefined1.09 B undefined339.9 M undefined
20066.27 B undefined1.13 B undefined586.4 M undefined
20055.46 B undefined1.01 B undefined546.3 M undefined
20045.07 B undefined880.9 M undefined499.2 M undefined

Quest Diagnostics Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)NET INCOME (B)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
1991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e
0.941.231.421.631.631.621.531.462.213.423.634.114.745.075.466.276.77.257.467.267.397.387.157.447.497.527.47.537.739.4410.799.889.259.9310.7911.1911.1111.4
-30.6115.2215.32-0.24-0.80-5.45-4.5851.2355.156.0213.2615.346.947.6814.886.968.132.84-2.621.80-0.12-3.204.040.780.29-1.501.742.5922.1514.32-8.39-6.387.338.623.73-0.712.66
41.1346.4643.0840.6039.8437.4436.9838.4837.4139.8740.6940.7741.5641.3940.9841.0340.8041.2942.0341.1841.2841.5739.8437.9238.2839.1136.8535.3335.2638.1839.6635.0633.1430.8828.4327.4027.6026.89
0.390.570.610.660.650.610.570.560.831.361.481.681.972.12.242.572.742.993.132.993.053.072.852.822.872.942.732.662.723.64.283.473.0700000
0.10.10.030.03-0.05-0.63-0.020.03-00.10.160.320.440.50.550.590.340.580.730.720.470.550.850.550.710.640.770.730.861.431.990.940.8511.11.21.31.43
--0.97-66.67-17.65-285.711,103.85-96.49-218.18-111.54-3,466.6760.4098.7735.4014.459.427.33-42.1571.0925.17-1.24-34.8718.4252.98-34.5227.44-9.0719.78-4.6816.6466.6739.51-52.62-9.7718.009.578.838.959.82
--------------------------------------
--------------------------------------
115.6115.6115.6115.6115.6115.3116.8120.9140.1188.6195.2205.3217.6214.1205.5199.5195.3196187.8177.3160.2160.115314514514214013913613612811811300000
--------------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Quest Diagnostics Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Quest Diagnostics is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (B)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (B)GOODWILL (B)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (B)PROVISIONS (B)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (M)OTHER LIAB. (B)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                           
0.040.040.040.160.20.030.170.120.10.160.070.090.150.170.250.530.450.170.30.190.190.130.360.140.141.191.160.870.320.69
0.360.320.30.240.220.540.490.510.520.610.650.730.770.880.830.830.850.910.870.850.930.90.930.921.011.061.521.441.21.21
003132160000000000000000000003000
2827293031524450617275787995102917789939111084829599123223208192190
73121112109107254279196145159133166189230307227234240305253369383164150144112154223196286
0.50.50.510.570.580.870.980.880.8310.931.071.191.381.51.681.611.41.561.381.61.51.531.311.392.493.062.741.92.37
0.290.30.290.250.240.430.450.510.570.610.620.750.750.910.880.830.830.80.760.810.930.931.031.151.291.972.232.32.352.42
000000000000000000000473443462436482521141132135
000000000000000000000000000000
1.051.030.550.510.51.440.030.030.020.020.010.150.190.890.830.820.81.040.870.91.070.980.951.121.211.121.171.171.091.17
0000001.241.351.792.522.513.23.395.225.065.085.15.85.545.656.035.9166.346.566.626.877.17.227.73
4224506547142172166119162135138134173145151189281559215218174148136119160176163144198
1.381.350.880.830.782.011.882.052.53.313.274.244.477.196.916.896.927.917.727.578.258.468.579.29.6110.3510.9710.8710.9411.65
1.881.851.41.41.362.882.862.933.334.34.25.315.668.578.48.568.539.319.288.959.869.9610.110.51112.8414.0313.6112.8414.02
                                                           
001111111112222222222222222222
0.30.31.171.21.21.51.591.721.822.272.22.182.192.212.262.32.312.352.372.382.422.482.552.612.672.722.842.262.32.32
0.09-0-0.63-0.65-0.62-0.63-0.53-0.36-0.040.380.821.291.82.062.563.223.874.264.695.365.726.26.617.147.68.179.37.658.298.83
32-1-6-7-14-37-17-944-10025-68-2111-814-8-27-38-72-48-59-47-29-15-22-15
0-1-4-100000000000000000000088111
0.390.30.540.540.570.861.031.341.772.653.023.463.994.34.765.56.196.617.087.738.128.649.099.710.2110.8612.139.910.5711.13
0.240.030.030.020.030.050.110.110.110.120.130.190.220.210.190.210.210.220.20.261.190.280.260.220.220.260.450.360.321.74
00.210.180.220.220.570.560.510.480.50.510.540.620.921.030.680.650.690.740.6600.670.650.650.60.731.061.191.030.92
36492218162918302029282900000510070616777102105119899984
130000000000335300100000850000071988815311692129
01221335145265126743752176451713495699212518159636464804222303
0.290.30.250.30.310.70.950.660.640.721.041.11.151.291.221.061.211.561.051.131.711.170.981.061.491.991.781.751.553.17
1.151.20.520.480.411.170.760.820.81.030.721.261.243.383.082.942.643.373.353.123.223.493.733.753.433.974.014.013.984.41
0000000000000000000000000000295270
0.060.060.090.080.070.140.120.120.120.150.150.190.250.580.480.560.620.670.70.720.590.510.650.660.751.121.351.291.011.11
1.211.260.610.560.481.310.880.940.921.180.871.441.493.953.553.493.264.044.053.843.824.014.384.414.175.095.365.35.285.79
1.51.560.860.860.792.011.831.591.561.911.912.542.645.244.784.554.475.65.14.985.535.185.365.475.667.087.147.056.838.96
1.881.851.41.41.362.882.862.933.334.564.9366.639.549.5410.0510.6612.2112.1812.7113.6413.8214.4515.1715.8717.9419.2616.9517.420.1
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Quest Diagnostics provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Quest Diagnostics's financial health and stability.

Assets

Quest Diagnostics's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Quest Diagnostics must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Quest Diagnostics after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Quest Diagnostics's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
1993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
0.030.03-0.05-0.63-0.020.03-00.10.160.320.440.50.550.590.370.610.770.760.510.590.880.590.750.70.820.790.911.52.081.020.91
668910199766890134147131153168176197237264256254281286283314304249270309329361408437439
-23-4-32-4-112-293309033520-46-1083-182861923112379731585-571-49
-89-141-84-176-33-27-8-139-144-202-222-226-176-147-266-296-528-241-511-163-372-326-36981-9-49352287119-145
1126515361915660199238300255261304305361590551495421663498-1163867312216014014135-206223196
416074914141621105856595150102157189146139161163167170172148159174192201159156134
5258211310162421268321220931438131535936242128530556832731936124384202360709283317
0.10.040.09-0.090.180.140.250.370.470.60.660.80.850.950.931.0611.120.91.170.670.940.821.121.181.21.242.012.231.721.27
-65-93-74-70-30-39-76-116-149-155-174-176-224-193-219-212-166-205-161-182-231-308-263-293-252-383-400-418-403-404-408
-473-46-93-63-35-39-1,108-48-296-477-417-173-1,079-414-1,759-198-195-216-1,243-217328-1,025-362-127-830-801-411-77221-543-1,061
-40847-196-40-1,03268-147-322-2422-855-221-1,54013-29-11-1,081-34559-717-99166-578-418-11-354424-139-653
0000000000000000000000000000000
0.440.070.040.05-0.02-0.050.72-0.19-0.21-0.160.06-00.64-0.041.02-0.440.01-0.170.98-0.65-00.37-0.080.140.020.120.83-0.81-0-00.75
0001190-123222427-227-625-291-370-64-223-412-701-798-37-899-54-164-517-335-223-234-136-2,070-1,285-203
39375157-21-60682-177-218-144-187-706247-480850-777-521-98663-822-1,10692-518-738-592-401225-1,267-2,540-1,732160
000-1002-41-8-37-12-18-18-2710-31-31-48-44-52-21-18-38-58-139-33-36-87-29-159-140-71
-51-60-37-10000000-61-69-77-77-78-74-71-64-108-185-187-212-223-247-266-286-297-309-305-314
0.020-00.010.120.04-0.180.14-0.05-0.030.06-0.080.020.060.020.090.28-0.09-0.280.13-0.110.01-0.060.25-0.25-01.06-0.03-0.29-0.560.37
34.3-55.411.8-158.9145.5101.8173.5253316.8441.2488.2622.7627.3758.5707.8850.3830.5912.6733.9987.74386305588239238178431,5871,8301,314864
0000000000000000000000000000000

Quest Diagnostics stock margins

The Quest Diagnostics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Quest Diagnostics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Quest Diagnostics.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Quest Diagnostics's sales revenue. A higher gross margin percentage indicates that the Quest Diagnostics retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Quest Diagnostics's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Quest Diagnostics's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Quest Diagnostics's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Quest Diagnostics. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Quest Diagnostics's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Quest Diagnostics Margin History

Quest Diagnostics Gross marginQuest Diagnostics Profit marginQuest Diagnostics EBIT marginQuest Diagnostics Profit margin
2028e33.14 %16.5 %12.55 %
2027e33.14 %16.04 %11.73 %
2026e33.14 %16.29 %10.69 %
2025e33.14 %15.85 %10.19 %
2024e33.14 %15.33 %10.11 %
202333.14 %14.22 %9.19 %
202235.06 %15.38 %9.53 %
202139.66 %23.15 %18.43 %
202038.18 %21.1 %15.1 %
201935.26 %17.1 %11.07 %
201835.33 %16.29 %9.73 %
201736.85 %17.16 %10.39 %
201639.11 %16.45 %8.54 %
201538.28 %14.73 %9.42 %
201437.92 %13.81 %7.45 %
201339.84 %15.63 %11.84 %
201241.58 %17.86 %7.49 %
201141.27 %17.57 %6.33 %
201041.2 %18.2 %9.88 %
200942.04 %18.05 %9.75 %
200841.29 %16.86 %8 %
200740.79 %16.28 %5.07 %
200641.04 %18 %9.35 %
200540.98 %18.46 %10.01 %
200441.39 %17.39 %9.85 %

Quest Diagnostics Stock Sales Revenue, EBIT, Earnings per Share

The Quest Diagnostics earnings per share therefore indicates how much revenue Quest Diagnostics has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Quest Diagnostics earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Quest Diagnostics's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Quest Diagnostics’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Quest Diagnostics's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Quest Diagnostics Revenue, EBIT and net profit per share

DateQuest Diagnostics Sales per ShareQuest Diagnostics EBIT per shareQuest Diagnostics Earnings per Share
2028e102.17 undefined0 undefined12.82 undefined
2027e99.53 undefined0 undefined11.68 undefined
2026e100.23 undefined0 undefined10.72 undefined
2025e96.63 undefined0 undefined9.85 undefined
2024e88.96 undefined0 undefined8.99 undefined
202381.88 undefined11.65 undefined7.52 undefined
202283.75 undefined12.88 undefined7.98 undefined
202184.28 undefined19.51 undefined15.53 undefined
202069.39 undefined14.64 undefined10.48 undefined
201956.81 undefined9.71 undefined6.29 undefined
201854.18 undefined8.83 undefined5.27 undefined
201752.87 undefined9.07 undefined5.49 undefined
201652.92 undefined8.7 undefined4.52 undefined
201551.68 undefined7.61 undefined4.87 undefined
201451.28 undefined7.08 undefined3.82 undefined
201346.71 undefined7.3 undefined5.53 undefined
201246.11 undefined8.24 undefined3.46 undefined
201146.14 undefined8.11 undefined2.92 undefined
201040.95 undefined7.45 undefined4.05 undefined
200939.7 undefined7.17 undefined3.87 undefined
200836.99 undefined6.24 undefined2.96 undefined
200734.33 undefined5.59 undefined1.74 undefined
200631.42 undefined5.65 undefined2.94 undefined
200526.55 undefined4.9 undefined2.66 undefined
200423.67 undefined4.11 undefined2.33 undefined

Quest Diagnostics business model

Quest Diagnostics Inc is a leading company in the field of diagnostic information and services, headquartered in New Jersey, USA. The company is dedicated to providing medical professionals and patients worldwide with fast, accurate, and preventive diagnostic tests. The history of Quest Diagnostics dates back to 1967 when the company MetPath was founded by Dr. Paul A. Brown. In the following years, several acquisitions and mergers took place, eventually leading to the establishment of Quest Diagnostics in 1996. Since then, the company has continuously evolved and now offers a wide range of diagnostic tests and services, ranging from the analysis of blood samples to genetic testing procedures. The business model of Quest Diagnostics is based on providing high-quality and individualized information to medical professionals and patients to assist in the diagnosis, treatment, and cure of their health problems. The company works closely with doctors, hospitals, and other medical institutions worldwide to offer a comprehensive range of innovative diagnostic products, procedures, and technologies tailored to meet specific needs. Quest Diagnostics offers a wide range of services, ranging from laboratory testing to data management and clinical trials. The company has various business segments, including the Diagnostic Services business, the Medical Research Services business, and the Information Services business. In the field of Diagnostic Services, Quest Diagnostics offers a broad spectrum of laboratory tests divided into different categories such as cancer diagnostics, cardiology, endocrinology, immunology, and infectious diseases. The company also provides a variety of genetic tests that enable precise analysis of individual genomes, supporting the diagnosis and treatment of various genetic disorders. In the medical research field, Quest Diagnostics provides a range of services to support clinical trials and drug development. The company also offers a wide range of laboratory tests used in biomedical research to improve people's health and well-being. The Information Services business segment of Quest Diagnostics mainly focuses on providing innovative solutions in the field of data management and information technology. This includes the development of software tools that can be used for the analysis and management of health data. Additionally, the company offers consulting services to help medical professionals address challenges related to information processing and data integration. Quest Diagnostics is a company based on innovation and knowledge that collaborates closely with doctors, clinics, and other medical facilities worldwide to offer a relatively comprehensive range of need-specific diagnostic products, procedures, and solutions. From cancer diagnostics to genomic diagnostics, from clinical trials to information and data services, and a wide range of molecular diagnostic tests and laboratory analyses, Quest Diagnostics provides top-notch solutions for optimal patient care, contributing to the goal of improving global healthcare for people worldwide. Quest Diagnostics is one of the most popular companies on Eulerpool.com.

Quest Diagnostics SWOT Analysis

Strengths

Quest Diagnostics Inc is a leading provider of diagnostic testing, information, and services, with a strong market presence and brand reputation.

The company has a vast network of laboratories and patient service centers, enabling it to serve a wide range of customers across the United States.

Quest Diagnostics Inc has developed advanced testing technologies and capabilities, allowing for accurate and reliable test results.

Weaknesses

Quest Diagnostics Inc faces intense competition in the diagnostic testing industry, which could impact its market share and pricing power.

The company relies on third-party payers, such as insurance companies, for a significant portion of its revenue, making it vulnerable to changes in reimbursement policies.

Quest Diagnostics Inc's operations are subject to various regulations and compliance requirements, which could increase costs and limit flexibility.

Opportunities

The increasing demand for personalized medicine and genetic testing presents growth opportunities for Quest Diagnostics Inc.

Expanding into emerging markets, such as Asia and Latin America, could help Quest Diagnostics Inc tap into new customer bases and drive revenue growth.

Technology advancements, such as the integration of artificial intelligence in diagnostics, offer opportunities for Quest Diagnostics Inc to enhance its testing capabilities and improve efficiency.

Threats

Changes in healthcare policies and regulations can pose significant challenges to Quest Diagnostics Inc's operations and profitability.

Increasing pricing pressure from payers and the growing trend of cost containment in healthcare could negatively impact Quest Diagnostics Inc's financial performance.

Competitors in the industry continuously strive to develop innovative diagnostic solutions, posing a threat to Quest Diagnostics Inc's market position.

Quest Diagnostics Revenue by Segment

  • 3 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Quest Diagnostics Revenue by Segment

Segmente2023202220212020201920182017201620152014201320122011
COVID-19 testing services--2.77 B USD2.72 B USD---------
Gene-based and esoteric (including advanced diagnostics) testing services--2.88 B USD2.1 B USD---------
Routine clinical testing and other services--4.29 B USD----------
Routine clinical testing services---3.84 B USD---------
Anatomic pathology testing services--553 M USD482 M USD---------
All other services--294 M USD298 M USD---------

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Quest Diagnostics Revenue by Segment

Segmente2023202220212020201920182017201620152014201320122011
Routine clinical testing services----4.21 B USD4.22 B USD4.31 B USD4.18 B USD-----
Gene-based and esoteric (including advanced diagnostics) testing services----2.62 B USD2.41 B USD2.45 B USD2.34 B USD-----
Anatomic pathology testing services----579 M USD578 M USD612 M USD624 M USD-----
All other services----321 M USD327 M USD339 M USD377 M USD-----

  • 3 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Quest Diagnostics Revenue by Segment

Segmente2023202220212020201920182017201620152014201320122011
DIS business8.98 B USD9.61 B USD10.49 B USD9.14 B USD---------

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Quest Diagnostics Revenue by Segment

Segmente2023202220212020201920182017201620152014201320122011
DIS business----7.41 B USD7.2 B USD7.37 B USD7.14 B USD6.97 B USD6.87 B USD6.59 B USD6.82 B USD-
Clinical laboratory testing business------------6.81 B USD
All other operating segments276 M USD274 M USD294 M USD298 M USD321 M USD327 M USD339 M USD377 M USD528 M USD562 M USD559 M USD562.65 M USD696.03 M USD
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Quest Diagnostics Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Quest Diagnostics historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Quest Diagnostics shares outstanding

The number of shares was Quest Diagnostics in 2024 — This indicates how many shares 113 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Quest Diagnostics earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Quest Diagnostics's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Quest Diagnostics’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Quest Diagnostics's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Quest Diagnostics stock splits

In Quest Diagnostics's history, there have been no stock splits.

Quest Diagnostics dividend history and estimates

In 2024, Quest Diagnostics paid a dividend amounting to 2.96 USD. Dividend means that Quest Diagnostics distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Quest Diagnostics provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Quest Diagnostics’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Quest Diagnostics's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Quest Diagnostics Dividend History

DateQuest Diagnostics Dividend
2028e3.12 undefined
2027e3.13 undefined
2026e3.13 undefined
2025e3.12 undefined
2024e3.13 undefined
20232.79 undefined
20222.6 undefined
20212.42 undefined
20202.21 undefined
20192.12 undefined
20181.95 undefined
20171.8 undefined
20161.58 undefined
20151.47 undefined
20141.29 undefined
20131.5 undefined
20120.68 undefined
20110.4 undefined
20100.4 undefined
20090.4 undefined
20080.4 undefined
20070.4 undefined
20060.39 undefined
20050.35 undefined
20040.3 undefined

Quest Diagnostics dividend payout ratio

In 2024, Quest Diagnostics had a payout ratio of 23.74%. The payout ratio indicates the percentage of the company's profits that Quest Diagnostics distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Quest Diagnostics represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Quest Diagnostics could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Quest Diagnostics's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Quest Diagnostics Payout Ratio History

DateQuest Diagnostics Payout ratio
2028e25.26 %
2027e24.88 %
2026e24.43 %
2025e26.46 %
2024e23.74 %
202323.08 %
202232.57 %
202115.58 %
202021.09 %
201933.76 %
201837 %
201732.79 %
201634.96 %
201530.18 %
201433.77 %
201327.17 %
201219.71 %
201113.75 %
20109.9 %
200910.31 %
200813.51 %
200722.99 %
200613.31 %
200513.02 %
200412.88 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Quest Diagnostics.

Quest Diagnostics latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20242.28 2.3  (0.8 %)2024 Q3
6/30/20242.36 2.35  (-0.44 %)2024 Q2
3/31/20241.87 2.04  (8.86 %)2024 Q1
12/31/20232.14 2.15  (0.69 %)2023 Q4
9/30/20232.21 2.22  (0.41 %)2023 Q3
6/30/20232.29 2.3  (0.48 %)2023 Q2
3/31/20231.99 2.04  (2.28 %)2023 Q1
12/31/20221.93 1.98  (2.76 %)2022 Q4
9/30/20222.22 2.36  (6.54 %)2022 Q3
6/30/20222.32 2.36  (1.94 %)2022 Q2
1
2
3
4
5
...
11

Eulerpool ESG Scorecard© for the Quest Diagnostics stock

Eulerpool World ESG Rating (EESG©)

82/ 100

🌱 Environment

99

👫 Social

99

🏛️ Governance

49

Environment

Scope 1 - Direct Emissions
288,624
Scope 2 - Indirect emissions from purchased energy
104,080
Scope 3 - Indirect emissions within the value chain
24,827,156
Total CO₂ emissions
392,704
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees72.371
Percentage of women in management
Percentage of Asian employees22.2
Share of Asian management12
Percentage of Hispanic/Latino employees12.1
Hispano/Latino Management share9.4
Percentage of Black employees15.6
Black Management Share12
Percentage of white employees47.1
White Management Share63.6
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Quest Diagnostics shareholders

%
Name
Stocks
Change
Date
12.45577 % The Vanguard Group, Inc.13,903,13230,4996/30/2024
5.67834 % BlackRock Institutional Trust Company, N.A.6,338,165-441,9596/30/2024
4.65208 % State Street Global Advisors (US)5,192,653-6,5416/30/2024
3.47941 % Victory Capital Management Inc.3,883,721-38,6106/30/2024
2.55744 % American Century Investment Management, Inc.2,854,614-1,019,1286/30/2024
2.30912 % Geode Capital Management, L.L.C.2,577,43643,8646/30/2024
2.28525 % Wellington Management Company, LLP2,550,792-61,9776/30/2024
2.14194 % Davis Selected Advisers, L.P.2,390,8289,6656/30/2024
1.90711 % Grantham Mayo Van Otterloo & Co LLC2,128,72185,4666/30/2024
1.88991 % Dimensional Fund Advisors, L.P.2,109,515129,3956/30/2024
1
2
3
4
5
...
10

Quest Diagnostics Executives and Management Board

Mr. James Davis

(60)
Quest Diagnostics Executive Chairman of the Board, President, Chief Executive Officer (since 2013)
Compensation 11.88 M

Mr. Sam Samad

(53)
Quest Diagnostics Chief Financial Officer, Executive Vice President
Compensation 6.27 M

Ms. Catherine Doherty

(60)
Quest Diagnostics Senior Vice President - Regional Businesses
Compensation 2.87 M

Mr. Michael Prevoznik

(61)
Quest Diagnostics Senior Vice President, General Counsel
Compensation 2.44 M

Mr. Patrick Plewman

(56)
Quest Diagnostics Senior Vice President - Diagnostic Services
Compensation 1.98 M
1
2
3
4

Quest Diagnostics Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Blackhawk Network Holdings, Inc. Stock
Blackhawk Network Holdings, Inc.
SupplierCustomer 0,230,01-0,28-0,44
Oxford Immunotec Global Plc Stock
Oxford Immunotec Global Plc
SupplierCustomer0,820,52-0,37-0,50
OptimizeRx Corporation Stock
OptimizeRx Corporation
SupplierCustomer0,750,050,270,740,400,65
Ortho Cli Dgnst Rg Stock
Ortho Cli Dgnst Rg
SupplierCustomer0,680,510,340,770,22
Siemens Healthineers AG Stock
Siemens Healthineers AG
SupplierCustomer0,640,820,470,800,790,89
LifeMD Stock
LifeMD
SupplierCustomer0,59-0,210,280,52-0,11-0,32
ProQR Therapeutics Stock
ProQR Therapeutics
SupplierCustomer0,580,130,330,750,530,31
Easterly Government Properties Stock
Easterly Government Properties
SupplierCustomer0,530,610,300,710,53-0,30
Ginkgo Bioworks A Stock
Ginkgo Bioworks A
SupplierCustomer0,52-0,10-0,030,830,43
BioNano Genomics Stock
BioNano Genomics
SupplierCustomer0,510,270,310,820,100,12
1
2

Most common questions regarding Quest Diagnostics

What values and corporate philosophy does Quest Diagnostics represent?

Quest Diagnostics Inc represents values of empowerment, collaboration, and integrity. As a leading provider of diagnostic testing and information services, the company is committed to delivering high-quality healthcare solutions. Quest Diagnostics believes in patient-centric care and strives to improve both individual and public health outcomes. With a corporate philosophy focused on innovation and excellence, Quest Diagnostics prioritizes accuracy, efficiency, and accessibility in their diagnostic services. Through extensive research and development, the company continually advances medical technologies to contribute to the progress of the healthcare industry.

In which countries and regions is Quest Diagnostics primarily present?

Quest Diagnostics Inc is primarily present in the United States.

What significant milestones has the company Quest Diagnostics achieved?

Quest Diagnostics Inc has achieved several significant milestones throughout its history. One of its noteworthy achievements includes the development of innovative diagnostic tests and services that have revolutionized the healthcare industry. Additionally, Quest Diagnostics Inc has successfully established a vast network of laboratories and patient service centers, ensuring convenient access to high-quality diagnostic information services for patients worldwide. Furthermore, the company has received numerous accolades for its commitment to quality, including ISO 9001 certification for its laboratory operations. These accomplishments highlight Quest Diagnostics Inc as a leading provider of diagnostic information services and showcase its dedication to improving patient care and outcomes.

What is the history and background of the company Quest Diagnostics?

Quest Diagnostics Inc is a leading provider of diagnostic information services. It was founded in 1967 as MetPath and became Quest Diagnostics in 1997. The company offers a wide range of services, including lab testing, clinical trials, and healthcare IT solutions. With a strong focus on innovation and quality, Quest Diagnostics has become a trusted name in the healthcare industry. It operates a vast network of laboratories across the United States, serving millions of patients and healthcare professionals. Quest Diagnostics is known for its commitment to accuracy, efficiency, and delivering timely results, making it a reliable partner for both patients and healthcare providers.

Who are the main competitors of Quest Diagnostics in the market?

The main competitors of Quest Diagnostics Inc in the market are Laboratory Corporation of America Holdings (LabCorp), Sonic Healthcare Limited, and Bio-Reference Laboratories.

In which industries is Quest Diagnostics primarily active?

Quest Diagnostics Inc is primarily active in the healthcare industry.

What is the business model of Quest Diagnostics?

Quest Diagnostics Inc. operates as a provider of diagnostic testing and information services. It offers a range of services including routine testing, complex and specialized testing, and diagnostic information services. The company operates a network of laboratories, patient service centers, and other testing sites across the United States. Quest Diagnostics Inc. collaborates with physicians, hospitals, and other healthcare organizations to help improve patient care. Its business model revolves around delivering accurate and reliable diagnostic testing results in a timely manner, assisting healthcare providers in making informed decisions, and ultimately improving patient outcomes.

What is the P/E ratio of Quest Diagnostics 2025?

The Quest Diagnostics P/E ratio is 16.47.

What is the P/S ratio of Quest Diagnostics 2025?

The Quest Diagnostics P/S ratio is 1.68.

What is the Quality Investing of Quest Diagnostics?

The Quality Investing for Quest Diagnostics is 4/10.

What is the revenue of Quest Diagnostics 2025?

The expected Quest Diagnostics revenue is 10.79 B USD.

How high is the profit of Quest Diagnostics 2025?

The expected Quest Diagnostics profit is 1.1 B USD.

What is the business model of Quest Diagnostics

Quest Diagnostics Inc is a leading provider of diagnostic laboratory tests and services worldwide. The company serves medical laboratories, hospitals, clinics, physicians, as well as companies and insurers globally. The company's business strategy is based on providing high-quality laboratory facilities, state-of-the-art technology, and a high-quality laboratory workflow management platform. It operates over 2,200 patient centers in the United States and also offers a mobile laboratory service. The company is divided into three main segments: 1. Diagnostic information services, 2. Diagnostic services, and 3. Diagnostic solutions. Quest Diagnostics offers a wide range of products and services used to diagnose and treat diseases and conditions, including blood tests, hormone analyses, microbiology tests, genetic tests, immunology tests, and more. The company also operates a pathology laboratory that provides specialized services for cancer diagnosis and other critical diseases. It has also specialized in the development of tests for detecting COVID-19. Overall, Quest Diagnostics has a strong business model based on its leading position in the diagnostic market, a wide range of products and services, and a strong presence in the United States and growing international presence. The company is also focused on expanding its capabilities in digital health technology to meet the changing healthcare landscape.

What is the Quest Diagnostics dividend?

Quest Diagnostics pays a dividend of 2.6 USD distributed over 4 payouts per year.

How often does Quest Diagnostics pay dividends?

Quest Diagnostics pays out a dividend 4 times a year.

What is the Quest Diagnostics ISIN?

The ISIN of Quest Diagnostics is US74834L1008.

What is the Quest Diagnostics WKN?

The WKN of Quest Diagnostics is 904533.

What is the Quest Diagnostics ticker?

The ticker of Quest Diagnostics is DGX.

How much dividend does Quest Diagnostics pay?

Over the past 12 months, Quest Diagnostics paid a dividend of 2.79 USD . This corresponds to a dividend yield of about 1.74 %. For the coming 12 months, Quest Diagnostics is expected to pay a dividend of 3.13 USD.

What is the dividend yield of Quest Diagnostics?

The current dividend yield of Quest Diagnostics is 1.74 %.

When does Quest Diagnostics pay dividends?

Quest Diagnostics pays a quarterly dividend. This is distributed in the months of May, August, November, February.

How secure is the dividend of Quest Diagnostics?

Quest Diagnostics paid dividends every year for the past 25 years.

What is the dividend of Quest Diagnostics?

For the upcoming 12 months, dividends amounting to 3.13 USD are expected. This corresponds to a dividend yield of 2.06 %.

In which sector is Quest Diagnostics located?

Quest Diagnostics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Quest Diagnostics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Quest Diagnostics from 1/29/2025 amounting to 0.75 USD, you needed to have the stock in your portfolio before the ex-date on 1/14/2025.

When did Quest Diagnostics pay the last dividend?

The last dividend was paid out on 1/29/2025.

What was the dividend of Quest Diagnostics in the year 2024?

In the year 2024, Quest Diagnostics distributed 2.79 USD as dividends.

In which currency does Quest Diagnostics pay out the dividend?

The dividends of Quest Diagnostics are distributed in USD.

All fundamentals about Quest Diagnostics

Our stock analysis for Quest Diagnostics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Quest Diagnostics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.